Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lasser

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
International Journal of Geriatric Psychiatry|September 8, 2004
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorderRobert A Lasser, Cynthia A Bossie, Young Zhu, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 7, 2007
Long-acting risperidone in young adults with early schizophrenia or schizoaffective illnessRobert A Lasser, Cynthia A Bossie, Young Zhu, et al.
Postgraduate Medicine|September 10, 2011
Managing ADHD across the lifespan in the primary care settingDavid W Goodman, Robert A Lasser, Thomas Babcock, et al.
International Journal of Geriatric Psychiatry|December 16, 1998
Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's diseaseR A Lasser, R Dukoff, J Levy, et al.
The Journal of Clinical Psychiatry|April 1, 1997
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapyJ A Bodkin, R A Lasser, J D Wines, et al.
Schizophrenia Research|May 26, 2005
Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesiaGeorges M Gharabawi, Cynthia A Bossie, Robert A Lasser, et al.
Radiology|August 1, 1995
Clinical safety of gadopentetate dimeglumineK L Nelson, L M Gifford, C Lauber-Huber, et al.
Schizophrenia Research|September 4, 2007
Remission in schizophrenia: applying recent consensus criteria to refine the conceptRobert A Lasser, Henry Nasrallah, Lars Helldin, et al.
Cell Reports|November 30, 2022
Madm/NRBP1 mediates synaptic maintenance and neurodegeneration-induced presynaptic homeostatic potentiationZeeshan Mushtaq, Kumar Aavula, Dario A Lasser, et al.
The Journal of Clinical Psychiatry|January 24, 2006
Methodological issues in a comparative study of ziprasidone and risperidoneGeorges M Gharabawi, Cynthia A Bossie, Ramy Mahmoud, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Geriatric Psychiatry|September 8, 2004
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorderRobert A Lasser, Cynthia A Bossie, Young Zhu, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 7, 2007
Long-acting risperidone in young adults with early schizophrenia or schizoaffective illnessRobert A Lasser, Cynthia A Bossie, Young Zhu, et al.
Postgraduate Medicine|September 10, 2011
Managing ADHD across the lifespan in the primary care settingDavid W Goodman, Robert A Lasser, Thomas Babcock, et al.
International Journal of Geriatric Psychiatry|December 16, 1998
Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's diseaseR A Lasser, R Dukoff, J Levy, et al.
The Journal of Clinical Psychiatry|April 1, 1997
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapyJ A Bodkin, R A Lasser, J D Wines, et al.
Schizophrenia Research|May 26, 2005
Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesiaGeorges M Gharabawi, Cynthia A Bossie, Robert A Lasser, et al.
Radiology|August 1, 1995
Clinical safety of gadopentetate dimeglumineK L Nelson, L M Gifford, C Lauber-Huber, et al.
Schizophrenia Research|September 4, 2007
Remission in schizophrenia: applying recent consensus criteria to refine the conceptRobert A Lasser, Henry Nasrallah, Lars Helldin, et al.
Cell Reports|November 30, 2022
Madm/NRBP1 mediates synaptic maintenance and neurodegeneration-induced presynaptic homeostatic potentiationZeeshan Mushtaq, Kumar Aavula, Dario A Lasser, et al.
The Journal of Clinical Psychiatry|January 24, 2006
Methodological issues in a comparative study of ziprasidone and risperidoneGeorges M Gharabawi, Cynthia A Bossie, Ramy Mahmoud, et al.
Pageof 7